EP0182372A3 - Faktor-VIII-gerinnende Polypeptide - Google Patents

Faktor-VIII-gerinnende Polypeptide Download PDF

Info

Publication number
EP0182372A3
EP0182372A3 EP85114743A EP85114743A EP0182372A3 EP 0182372 A3 EP0182372 A3 EP 0182372A3 EP 85114743 A EP85114743 A EP 85114743A EP 85114743 A EP85114743 A EP 85114743A EP 0182372 A3 EP0182372 A3 EP 0182372A3
Authority
EP
European Patent Office
Prior art keywords
factor viii
polypeptides
new factor
viii coagulant
coagulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP85114743A
Other languages
English (en)
French (fr)
Other versions
EP0182372A2 (de
Inventor
Theodore S. Zimmerman
Carol A. Fulcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of EP0182372A2 publication Critical patent/EP0182372A2/de
Publication of EP0182372A3 publication Critical patent/EP0182372A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/10—Factor VIII, AHF; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP85114743A 1984-11-21 1985-11-19 Faktor-VIII-gerinnende Polypeptide Withdrawn EP0182372A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/673,916 US4657894A (en) 1983-03-31 1984-11-21 New factor VIII coagulant polypeptides
US673916 1996-07-01

Publications (2)

Publication Number Publication Date
EP0182372A2 EP0182372A2 (de) 1986-05-28
EP0182372A3 true EP0182372A3 (de) 1988-09-14

Family

ID=24704615

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85114743A Withdrawn EP0182372A3 (de) 1984-11-21 1985-11-19 Faktor-VIII-gerinnende Polypeptide

Country Status (8)

Country Link
US (1) US4657894A (de)
EP (1) EP0182372A3 (de)
JP (1) JPS61137824A (de)
AU (1) AU576276B2 (de)
DK (1) DK538785A (de)
FI (1) FI854574L (de)
NO (1) NO854649L (de)
ZA (1) ZA858904B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362854A (en) * 1983-03-31 1994-11-08 Scripps Clinic & Research Foundation Factor VIII coagulant polypeptides: method of making
US4886876A (en) * 1983-03-31 1989-12-12 Scripps Clinic And Research Foundation Factor VIII coagulant polypeptides
US5747337A (en) * 1983-03-31 1998-05-05 The Scripps Research Institute Factor VIII coagulant polypeptides and monoclonal antibodies to them
US4857635A (en) * 1983-03-31 1989-08-15 Scripps Clinic And Research Foundation Factor VIII coagulant polypeptides and monoclonal antibodies tof them
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
DE3586402T3 (de) * 1984-01-12 2004-12-23 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Proteinzusammensetzung mit Koagulations-wirkung und Verfahren zu ihrer Herstellung.
JPH0764879B2 (ja) * 1984-01-12 1995-07-12 チロン コ−ポレイシヨン フアクタ−ｖ▲ｉｉｉ▼ｃに対するモノクロ−ナル抗体
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5595886A (en) 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
FI98829C (fi) * 1986-01-27 1997-08-25 Chiron Corp Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
FR2613379B2 (fr) * 1987-04-03 1990-04-06 Transgene Sa Procede de preparation de fragments du facteur viii a partir de cellules de mammiferes
EP0251843A1 (de) * 1986-06-06 1988-01-07 Transgene S.A. Verfahren zur Herstellung von Faktor VIII aus Säugerzellen
AU607927B2 (en) * 1986-06-24 1991-03-21 Nordisk Gentofte A/S A process for producing a coagulation active complex of factor viii fragments
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4980456A (en) * 1987-04-06 1990-12-25 Scripps Clinic And Research Foundation Recombinant factor VIIIC derived fragments
US6060447A (en) * 1987-05-19 2000-05-09 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
IE69026B1 (en) 1987-06-12 1996-08-07 Immuno Ag Novel proteins with factor VIII activity process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
US6346513B1 (en) 1987-06-12 2002-02-12 Baxter Trading Gmbh Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
US4831118A (en) * 1987-08-07 1989-05-16 Scripps Clinic And Research Foundation Flouroplastic immunoaffinity columns for purification of blood proteins
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
US20060122376A1 (en) * 1991-02-07 2006-06-08 Chiron Corporation Protein complexes having factor VIII:C activity and production thereof
JPH04133616U (ja) * 1991-05-31 1992-12-11 金子農機株式会社 共同乾燥施設における昇降機設置装置
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
CA2312291A1 (en) * 1997-12-05 1999-06-17 The Immune Response Corporation Novel vectors and genes exhibiting increased expression

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123945A1 (de) * 1983-03-31 1984-11-07 The Scripps Research Institute Neue Faktor VIII Polypeptidkoagulantien
EP0150735A2 (de) * 1984-01-12 1985-08-07 Chiron Corporation Proteinzusammensetzung mit Koagulations-wirkung und Verfahren zu ihrer Herstellung
EP0160457A1 (de) * 1984-04-20 1985-11-06 Genentech, Inc. Menschlicher Faktor VIII, diesen enthaltende Zusammensetzungen sowie Verfahren und Materialien, die für seine Herstellung Verwendung finden
EP0182448A2 (de) * 1984-08-24 1986-05-28 Genetics Institute, Inc. Verfahren zur Herstellung von Faktor VIII und verwandte Produkte

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123945A1 (de) * 1983-03-31 1984-11-07 The Scripps Research Institute Neue Faktor VIII Polypeptidkoagulantien
EP0150735A2 (de) * 1984-01-12 1985-08-07 Chiron Corporation Proteinzusammensetzung mit Koagulations-wirkung und Verfahren zu ihrer Herstellung
EP0160457A1 (de) * 1984-04-20 1985-11-06 Genentech, Inc. Menschlicher Faktor VIII, diesen enthaltende Zusammensetzungen sowie Verfahren und Materialien, die für seine Herstellung Verwendung finden
EP0182448A2 (de) * 1984-08-24 1986-05-28 Genetics Institute, Inc. Verfahren zur Herstellung von Faktor VIII und verwandte Produkte

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NATURE, vol. 312, no. 5992, 22nd November 1984, pages 337-342, London, GB; G.A. VEHAR et al.: "Structure of human factor VIII" *

Also Published As

Publication number Publication date
FI854574A0 (fi) 1985-11-20
FI854574A7 (fi) 1986-05-22
FI854574L (fi) 1986-05-22
DK538785A (da) 1986-05-22
NO854649L (no) 1986-05-22
DK538785D0 (da) 1985-11-21
JPS61137824A (ja) 1986-06-25
AU5025385A (en) 1986-05-29
EP0182372A2 (de) 1986-05-28
AU576276B2 (en) 1988-08-18
US4657894A (en) 1987-04-14
ZA858904B (en) 1986-08-27

Similar Documents

Publication Publication Date Title
EP0138854A4 (de) Antigen aktive aminosäuresequenzen.
AU7982387A (en) Amino acid derivates
EP0168063A3 (de) Peptide, welche als Zwischenverbindungen dienen bei der Herstellung von physiologisch aktiven Peptiden
AU8171282A (en) 5 oxo-thiazolo(3,2-a)azepine-3-carboxylic acids
AU576276B2 (en) Coagulation factor viii:c polypeptides
AU1731288A (en) 1,4-Benzoxazine-6-carboxylic acids
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
AU4292785A (en) Atrial peptide analogs
KR0180256B1 (en) Bpc peptides, their preparation and use
GB8518793D0 (en) Hypotensive active peptides
AU4042585A (en) Substituted alpha amino acids
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
IT8421622A0 (it) Procedimento per la preparazione di peptidi.
AU7905881A (en) Sulfonated amino acids
AU570572B2 (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
IE902388L (en) Vasoactive intestinal peptide analogs.
AU575725B2 (en) Improved protein hydrolysate
AU1704988A (en) Peptide production by protein engineering
IE863290L (en) Substituted piperazine-1, 4-naphthalenediones
ZA856691B (en) Amino acid derivatives
AU7969187A (en) Amino acid composition
EP0312346A3 (en) E. coli sequence specific acid protease
EP0261239A4 (de) Fsh-stimulierendes peptid.
AU4027285A (en) Novel cyclosporins
AU571050B2 (en) N-substituted amino propane sulfonic acid derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19890210

17Q First examination report despatched

Effective date: 19910502

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19920114

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FULCHER, CAROL A.

Inventor name: ZIMMERMAN, THEODORE S.